ONWARD Medical Schedules Webcast to Report Full-Year 2025 Financial Results

Got story updates? Submit your updates here. ›

ONWARD Medical N.V., the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury and other movement disabilities, announced that it will report Full-Year 2025 Financial Results and host a webcast to provide a comprehensive business update on March 31, 2026.

Why it matters

ONWARD Medical is at the forefront of developing innovative neurotechnology solutions to address the unmet needs of individuals with spinal cord injuries and other movement disabilities. The upcoming webcast will provide investors and the public with an in-depth look at the company's financial performance and progress in advancing its proprietary ARC Therapy and investigational ARC-IM system.

The details

The webcast, presented by CEO Dave Marver, will be held at 2:00 p.m. CEST / 08:00 a.m. ET on March 31, 2026. ONWARD Medical has been awarded 10 Breakthrough Device Designations from the FDA for its ARC Therapy and is currently commercializing its ARC-EX System in the US and Europe. The company is also developing the ARC-IM, an investigational implantable system designed to address several unmet needs including blood pressure instability after spinal cord injury.

• ONWARD Medical will report Full-Year 2025 Financial Results on March 31, 2026.
• The webcast will be held at 2:00 p.m. CEST / 08:00 a.m. ET on March 31, 2026.

What’s next

Investors and the public can register to join the webcast using the provided link.